Eloquest Healthcare News and Events

Excellent results of a clinical study titled, “Securement to prevent non-cuffed central venous catheter dislodgement in pediatrics The SECURED superiority randomized clinical trial,” have recently been published. Read More.

The prestigious award is based entirely on what current employees say about their experience working at Eloquest. This year, 100% of employees said it’s a great place To Work – 43 points higher than the average U.S. company. Read more.

Vascular access expert Michelle Hawes, DNP, RN, CRNI, VA-BC, will present the results of a large retrospective study on PICC securement at the upcoming 2023 Annual Scientific Meeting of the Association for Vascular Access, according to Eloquest Healthcare, Inc., a privately held medical device company. Read more.

Eloquest Healthcare is proud to sponsor the Association for Professionals in Infection Control and Epidemiology public service campaign, International Infection Prevention Week, which aims to raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health and will take place October 16-22. Read More.

A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, compared to either suture-based or adhesive device-based securement methods. Read More.

A study at Dignity Health Mercy General Hospital showed that use of a special liquid adhesive to increase the durability of driveline (DL) dressings can reduce the risk of infection and improve quality of life for heart failure patients with left ventricular assist devices (LVADs). Read more.

The partnership adds the revolutionary SecurAcath device to Eloquest Healthcare’s existing clinically oriented product offering. Read more.

In 2019 and again in September of 2020, Eloquest Healthcare partnered with Adventist Health Global Missions to support their efforts of providing care and performing surgeries in remote communities abroad without access to these services.

Eloquest Healthcare is excited to announce new, 5-year MedSurg agreement with group purchasing organization Vizient Supply, LLC that will include Mastisol^® Liquid Adhesive, Detachol^® Adhesive Remover and ReliaTect^® Post-Op Dressing with CHG. Under the new agreement, Vizient members can take advantage of special pricing for these products.